Day: October 25, 2021

Earnings Call taking place at 9:05 a.m. ET expected to include discussion of abstracts accepted to the upcoming 63rd American Society of Hematology (ASH) Annual Meeting BOSTON, Oct. 25, 2021 (GLOBE NEWSWIRE) — X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel CXCR4-targeted small molecule therapeutics to benefit patients with diseases of the immune system, today announced that it will report its financial results for the third quarter ended September 30, 2021, and provide an update on recent business highlights, on November 4, 2021. The company will host a conference call and webcast on the same day at 9:05 a.m. ET to discuss these financial results and business highlights. The company also anticipates discussion of abstracts accepted to the upcoming 63rd American Society of Hematology...

Call scheduled for Thursday, November 11th at 4:30 pm Eastern Time GARDEN CITY, N.Y., Oct. 25, 2021 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension, and gaseous NO (gNO) for the treatment of solid tumors, today announced that it will report financial results for its second fiscal quarter ended September 30, 2021 on Thursday, November 11, 2021. The Company’s management team is scheduled to host a conference call and webcast at 4:30 pm Eastern Time the same day.Conference Call & WebcastThursday, November 11th @ 4:30 PM ETDomestic: 877-407-0784International: 201-689-8560Passcode: 13722892Webcast: http://public.viavid.com/index.php?id=146470About...

Magnite’s “CTV Is for Everyone: US 2021” study finds ad-supported programming is becoming the primary way Americans watch CTV NEW YORK, Oct. 25, 2021 (GLOBE NEWSWIRE) — Magnite (NASDAQ: MGNI), the world’s largest independent omnichannel sell-side advertising platform, today released its “CTV Is for Everyone: US 2021” report. The study of 1,200 consumers across the US explores the opportunity for marketers to engage with CTV audiences which are now more reflective of the general population in terms of age, race, and other factors than traditional TV. “CTV is now much more than just an audience extension tool or an add-on to a linear buy because it’s clear that a large portion of TV viewers have shifted their attention in favor of CTV,” said Sean Buckley, Chief Revenue Officer, CTV of Magnite. “While traditional TV audiences have...

VANCOUVER, British Columbia, Oct. 25, 2021 (GLOBE NEWSWIRE) — ESE Entertainment Inc. (“we”, “ESE”, or the “Company”) (TSXV: ESE) (OTCQB: ENTEF) is pleased to announce, further to its press release on September 30, 2021, that it has entered into a binding share purchase agreement (the “Agreement”) to acquire Frenzy sp. z.o.o. (“Frenzy”), a European esports media and technology company. Frenzy is a media and production infrastructure company focused on the video game industry. The company creates and executes esports and gaming events, broadcasts, and media content. It also operates professional mobile, automated TV equipment, allowing it to produce reality shows from every part of the globe. Its main revenue streams include TV production, events and league organizations, and advertising campaigns. Frenzy is founded and majority...

– Study shows 45% (181/405) of patients with moderate-to-severe unexplained gastrointestinal symptoms who underwent upper endoscopy with biopsy met the histologic criteria for eosinophilic gastritis and/or eosinophilic duodenitis (EG/EoD) –– Presentation selected for “ACG Presidential Poster Award” – REDWOOD CITY, Calif., Oct. 25, 2021 (GLOBE NEWSWIRE) — Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing investigational medicine lirentelimab (AK002) for the treatment of eosinophil and mast cell-related diseases, today announced that its poster, “High Discovery Rate of Eosinophilic Gastritis and/or Duodenitis Among Patients with Chronic Unexplained Gastrointestinal Symptoms,” received a Presidential Poster Award at the American College of Gastroenterology (ACG) 2021 Annual Scientific Meeting. The poster...

AC5® Advanced Wound System Selected for Innovation Spotlight FRAMINGHAM, Mass., Oct. 25, 2021 (GLOBE NEWSWIRE) — Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical devices, today announced that it will be presenting at the 2021 Symposium on Advanced Wound Care (SAWC) Fall. The event is being held at Caesars Palace, Las Vegas, Nevada from October 29-31, 2021. The Company will be discussing AC5® Advanced Wound System at the “Innovation Spotlight: Shining a Light on Bold Ideas in Wound Care” between 11:20 AM-12:20 PM PT in the Julius 7-10 Conference Room at Caesars Palace on October 31, 2021. The presentation will highlight the use of AC5® Advanced Wound System in patients with chronic and non-healing wounds. In addition to its symposium presentation,...

Patent provides protection for oral dosage forms of ketamine-based preclinical candidate, SPL801B, as a sole treatment and in combination with a serotonin modulator LONDON, Oct. 25, 2021 (GLOBE NEWSWIRE) — Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a neuropharmaceutical company focused on psychedelic-assisted therapies, today announced that it has received European patent grant number EP 3 463 323 as acceptance for its European patent application No. 17 728640.8. The patent grants certain protections for oral dosage forms of a range of 2R,6R-hydroxynorketamine (“6-HNK”) based compounds, including the Company’s preclinical candidate SPL801B, for the treatment of depressive disorders. Peter Rands, Chief Executive Officer of Small Pharma, said: “We continue to experience rapid maturation both in...

Earnings Release: Wednesday, October 27, 2021, Before Market OpensConference Call and Webcast: Wednesday, October 27, 2021, at 8:30 a.m. ET MONACO, Oct. 25, 2021 (GLOBE NEWSWIRE) — Costamare Inc. (NYSE:CMRE), announced today that it will release its results for the third quarter ended September 30, 2021 before the market opens in New York on Wednesday, October 27, 2021. Conference Call Details: On Wednesday, October 27, 2021 at 8:30 a.m. ET, Costamare’s management team will hold a conference call to discuss the financial results. Participants should dial into the call 10 minutes before the scheduled time using the following numbers: 1-844-887-9405 (from the US), 0808-238-9064 (from the UK) or +1-412-317-9258 (from outside the US). Please quote “Costamare”. A replay of the conference call will be available until November...

BEVERLY, Mass., Oct. 25, 2021 (GLOBE NEWSWIRE) — LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing for veterinary diagnostics and biopharmaceutical manufacturing, today announced it has completed its analytical studies required by the FDA for an Emergency Use Authorization (EUA) application for COVID-19 diagnostics. LexaGene is in the process of completing the necessary work to have the FDA rule on authorizing the MiQLab™ for COVID-19 testing. The FDA is expected to classify the MiQLab as a class II medical device. As such, the process of preparing its point-of-care (POC) fully-automated PCR system, which is comprised of hardware, firmware, software, and chemistry, for evaluation by the FDA,...

Los Angeles, CA., Oct. 25, 2021 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, is pleased to announce that it will be featured as a presenting company at the Benzinga October Global Small Cap Conference. The conference is taking place virtually from October 27-28, 2021. The event bridges the gap between small cap companies, investors and traders. From the simplest lessons to expert strategies, attendees will receive insights on leadership, business fundamentals and plans for expansion. Cameron Chell, Chairman and CEO of Draganfly, will provide an overview of the Company’s business at 11:10AM EST on October 28, 2021. If you are an institutional or retail investor, and would like to listen to the Company’s...